@kravietz ...except not everyone is immediately at risk to get infected with COVID-19, whereas, in the optimal case, everyone gets vaccinated.
Also the deaths have been due to a very specific kind of blood clot, that does show up extremely rarely otherwise (so that risk table is off in general).
Most European countries seem to go the way of excluding the currently apparent risk group and recommend to use a different vaccine for those. Nothing is lost in terms of general progress.
I would personally accept any vaccine, including Sputnik, if someone would offer it to me. I'm 45 and by UK schedule I will get the 1st dose by June and while so far I avoided getting infected, the risk from Covid-19 is much much larger than any risks from vaccines so this is rather simple risk assessment from my point of view.
@kravietz Oh, personally, I'll totally get any vaccination that's available to me too - but in general it won't change a lot to wait for the AstraZeneca problem to be pinned down, at least as long es there are enough people waiting that are out of the currently obvious risk group (as large as it is). The current recommendation in Germany is to not use AstraZeneca on people younger than 60.
(And apparently I have that other instance you've been replying to on my blocklist, so yay!)
> to not use AstraZeneca on people younger than 60
I believe that by doing so Germany is "focusing on completely wrong risk", to quote Bruno Waterfield...
https://www.thetimes.co.uk/article/the-eus-risk-aversion-cost-thousands-of-lives-pzfdb9j8r
(Just ignore the fact that he had mixed up EU with EU national governments but that's quite common among Brits.)
@kravietz @smpl For Germany at least, it doesn't currently matter in practice, as there are not enough doses of any available vaccine to go through the current priority groups (which are mostly outside of the known AstraZeneca risk group).
Initially, AstraZeneca wasn't approved for older people here since the original trial group didn't include enough of those, and it was mostly given to younger prioritized people (nurses and such), where then the cases of blood clots showed up.